PaxMedica to Present at the Jan 26th Virtual Investor Summit Microcap Event
January 20 2023 - 1:31PM
via NewMediaWire -- PaxMedica, Inc. (Nasdaq: PXMD),
a clinical stage biopharmaceutical company focusing on the
development of novel anti-purinergic drug therapies (“APT”) for the
treatment of disorders with intractable neurologic symptoms, today
announced that it will be presenting virtually at the
upcoming Virtual Investor Summit on January 26th.
Event: Q1
Investor Summit
Date: Thursday,
January 26th, 2023
Presentation: January
26th at 1:30 PM ET
Location:
https://us06web.zoom.us/webinar/register/WN_LRZ8iM38TTCNpbbgvkUvCA
- The theme is 25 micro-cap
companies with a catalyst and/or strong performance in the current
market
- 1x1s will be available for
qualified investors
- The conference is
completely complimentary to qualified investors. Please register
at Complimentary Investor Registration
About PaxMedica
PaxMedica is a clinical stage biopharmaceutical
company focusing on the development of anti-purinergic drug
therapies (“APT”) for the treatment of disorders with intractable
neurologic symptoms, ranging from neurodevelopmental disorders,
including Autism Spectrum Disorder (“ASD”), to Myalgic
Encephalomyelitis/Chronic Fatigue Syndrome (“ME/CFS”), a
debilitating physical and cognitive disorder believed to be viral
in origin and now with rising incidence globally due to the long
term effects of SARS-CoV-2 (“COVID-19”). One of PaxMedica’s primary
points of focus is the development and testing of its lead program,
PAX-101, an intravenous formulation of suramin, in the treatment of
ASD and the advancement of the clinical understanding of using that
agent against other disorders such as ME/CFS and Long COVID-19
Syndrome, a clinical diagnosis in individuals who have been
previously infected with COVID-19. For more information, please
visit: www.paxmedica.com
About the Investor Summit
The Investor Summit is an exclusive,
independent conference dedicated to connecting smallcap and
microcap companies with qualified investors. The Q1 Investor Summit
will take place virtually, featuring 30 companies and over 120
institutional, family office, and high net worth investors. Sectors
Participating: Biotech, Communication Services, Consumer, Energy,
Technology, Financial, Healthcare, Industrials, Materials, Real
Estate. Contact: emily@investorsummitgroup.com
Contacts:
ir@paxmedica.com
Stephanie PrincePCG
Advisorysprince@pcgadvisory.com(646) 863-6341
PaxMedica (NASDAQ:PXMD)
Historical Stock Chart
From Aug 2024 to Sep 2024
PaxMedica (NASDAQ:PXMD)
Historical Stock Chart
From Sep 2023 to Sep 2024